Business Context and Reporting Period
Company: Achieve Life Sciences, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 7, 2018
Reporting Period: Third Quarter of 2018
This filing serves as a notification that the Company issued a press release on November 7, 2018, announcing its financial results for the third quarter of 2018. The press release is included as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data. It references a press release (Exhibit 99.1) for the actual figures. Consequently, the following metrics are not available in this document:
- Revenue
- Profit/Loss
- Cash Flow
- Margins
- Debt and Liquidity
Note: The filing text does not provide a clear value for any financial metric.
Material Changes
No material changes regarding financial performance or operations are detailed in this specific text. The document solely announces the release of Q3 2018 results.
Guidance, Outlook, and Risks
The text does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies. These items are presumed to be contained within the referenced press release (Exhibit 99.1), which is not included in the input text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for actual Q3 2018 revenue, net income, and cash position figures.
- Verify the Company's liquidity status and burn rate as of September 30, 2018.
- Check for any updates on clinical trial progress or regulatory milestones mentioned in the press release.
- Confirm if the Company provided updated full-year 2018 guidance in the press release.